PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies
PepsiCo’s core margin fell 15 basis points in the first half as price cuts and new products failed to offset weaker snack volumes, analysts said.
4 Articles
4 Articles
PepsiCo's fizz fades as GLP-1 drugs and activist investor Elliott's targets test its snack business
PepsiCo faces challenges in achieving its growth and margin targets due to rising competition and increased input costs. The company has seen a decline in its North American business, impacting sales volumes and market share. Healthier product offerings have been introduced in response to market changes and consumer preferences. Analysts predict modest revenue growth but express concerns about long-term recovery.
PepsiCo under pressure as weight-loss drug boom challenges growth goals
Washington: PepsiCo is running out of time to achieve the growth and profitability targets it outlined after activist investor Elliott Investment Management acquired a stake worth about $4 billion last year, as the growing popularity of GLP-1 weight-loss drugs continues to reshape consumer eating habits.Attention will be focused on PepsiCo’s third-quarter results, due on Thursday, with investors watching closely for signs of improvement in its k…
PepsiCo running out of time to meet Elliott-inspired targets as GLP-1 threat intensifies
(Refiles to fix dateline) By Alexander Marrow and Anuja Bharat Mistry Oct 7 (Reuters) - PepsiCo is running out of time to deliver on the growth and margin targets it set out after activist investor Elliott Investment Management took a roughly $4 billio...
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
